Company intelligence / Profile preview
Orbsen Therapeutics
GALWAY, Ireland
- Ownership
- Private
- Development stage
- Other
01
Overview
Orbsen Therapeutics has reported encouraging interim results from the NEPHSTROM proof-of-concept clinical study evaluating its lead product, ORBCEL™, in patients with diabetes and advanced chronic kidney disease. The NEPHSTROM trial is a randomized, double-blind, placebo-controlled Phase 1/2a study showing safety, tolerability, and preliminary efficacy of this allogeneic stromal cell therapy. Additional programs are in earlier clinical or preclinical stages targeting other inflammatory and degenerative diseases[6].
- Therapeutic areas
- PulmonologyOphthalmologyGastroenterologyEndocrinologyNephrologyImmunology
- Modalities
- Cell therapyStromal cell therapyAllogeneic bone marrow-derived stromal cell therapy (ORBCEL™)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
EU Horizon2020-funded consortia including multiple European academic medical centers [6]Collaborations with ~30 independent research laboratories across the EU [2]
Beyond the preview
Go deeper on Orbsen Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orbsen Therapeutics.